Cargando…

Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis

Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for the ideal treatment of anemia in chronic kidney disease (CKD) patients. Reduced frequency of administration along with a possibly lower cost as a result of simpler manufacturing techniques compared with other availabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaushik, Tarun, Yaqoob, Muhammad Magdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848525/ https://www.ncbi.nlm.nih.gov/pubmed/24348017 http://dx.doi.org/10.2147/BTT.S34935

Ejemplares similares

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis
por: Mikhail, Ashraf
Publicado: (2012)

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide
por: Valliant, Amanda, et al.
Publicado: (2013)

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis
por: Naik, Himanshu, et al.
Publicado: (2013)

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
por: Besarab, Anatole, et al.
Publicado: (2012)

Effects of Peginesatide Injection on QTc Interval in Healthy Adults
por: Czerniak, Richard, et al.
Publicado: (2014)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

An Update on the Controversies in Anemia Management in Chronic Kidney Disease: Lessons Learned and Lost
por: Teehan, Geoffrey, et al.
Publicado: (2011)

Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in rats
por: Woodburn, Kathryn W., et al.
Publicado: (2011)

The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease
por: Hull, Sally, et al.
Publicado: (2011)

Ethnic/Race Diversity and Diabetic Kidney Disease
por: Muthuppalaniappan, Vasantha Muthu, et al.
Publicado: (2015)

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)
por: Gang, Sishir, et al.
Publicado: (2022)

Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
por: Hildegard Stancu, Simona, et al.
Publicado: (2018)

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease
por: Li, Jia-Lin, et al.
Publicado: (2023)

Is hepcidin related with anemia and bone mineral metabolism in children with non-dialysis chronic kidney disease?
por: Yeşilbaş, Osman, et al.
Publicado: (2019)

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial
por: Singh, Ajay K., et al.
Publicado: (2022)

Incidence, prevalence, and treatment of anemia of non-dialysis-dependent chronic kidney disease: A retrospective database study in France
por: Dardim, Karim, et al.
Publicado: (2023)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
por: Hirai, Keiji, et al.
Publicado: (2023)

Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients
por: Casadevall, Nicole, et al.
Publicado: (2017)

Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study
por: Toft, Gunnar, et al.
Publicado: (2019)

Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study
por: Mathur, Rohini, et al.
Publicado: (2018)

Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
por: Nagaraju, Shankar P, et al.
Publicado: (2013)

Anemia in children with chronic kidney disease
por: Koshy, Susan M., et al.
Publicado: (2007)

Anemia, Diabetes, and Chronic Kidney Disease
por: Mehdi, Uzma, et al.
Publicado: (2009)

Is lack of suitable housing a barrier to home-based dialysis therapy for patients with end-stage renal disease? A cohort study
por: Forbes, Suzanne H, et al.
Publicado: (2013)

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
por: Akizawa, Tadao, et al.
Publicado: (2019)

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective
por: Gauthier-Loiselle, Marjolaine, et al.
Publicado: (2021)

Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease
por: Covic, Adrian, et al.
Publicado: (2017)

Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure
por: Šalamon, Špela, et al.
Publicado: (2021)

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
por: Park, Haesuk, et al.
Publicado: (2018)

Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials
por: Ye, Yuqiu, et al.
Publicado: (2018)

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2020)

Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries
por: Fliser, Danilo, et al.
Publicado: (2023)

The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
por: Zhou, Qiaoqiao, et al.
Publicado: (2023)

Treatment of anemia in chronic kidney disease: known, unknown, and both
por: Foley, Robert N
Publicado: (2011)

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
por: Yarnoff, Benjamin O., et al.
Publicado: (2016)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
por: Dahl, Naomi V, et al.
Publicado: (2017)

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)
por: Shutov, Evgeny, et al.
Publicado: (2021)

The efficacy of Roxadustat for the treatment of anemia in dialysis dependent chronic kidney disease patients: an updated systematic review and meta-analysis of randomized clinical trials
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
por: Sinha, Shubhadeep D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fnfi8bhcqengvl4eb0fpbjnj75